|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn874146249 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
090819s2010 enka ob 001 0 eng d |
| 040 |
|
|
|a E7B
|b eng
|e rda
|e pn
|c E7B
|d OCLCO
|d N$T
|d YDXCP
|d IDEBK
|d EBLCP
|d OCLCQ
|d D6H
|d COCUF
|d AGLDB
|d MOR
|d CCO
|d PIFPO
|d ZCU
|d MERUC
|d OCLCQ
|d OCLCO
|d OCLCA
|d U3W
|d OCLCO
|d OCLCF
|d STF
|d VNS
|d OCLCO
|d VTS
|d NRAMU
|d EZ9
|d ICG
|d VT2
|d TOF
|d OCLCQ
|d WYU
|d OCLCO
|d OCLCA
|d TKN
|d OCLCO
|d DKC
|d OCLCO
|d OCLCQ
|d M8D
|d UKAHL
|d OCLCQ
|d OCLCA
|d AJS
|d HS0
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 015 |
|
|
|a GBA989346
|2 bnb
|
| 016 |
7 |
|
|a 015366929
|2 Uk
|
| 019 |
|
|
|a 868069186
|a 869435448
|a 923424667
|a 961550334
|a 962576901
|a 1055319069
|a 1065697270
|a 1081260219
|a 1227639229
|
| 020 |
|
|
|a 9781908986597
|q (e-book)
|
| 020 |
|
|
|a 190898659X
|q (e-book)
|
| 020 |
|
|
|z 9781903378717
|
| 020 |
|
|
|z 1903378710
|
| 029 |
1 |
|
|a AU@
|b 000053336783
|
| 029 |
1 |
|
|a DEBBG
|b BV043785500
|
| 029 |
1 |
|
|a DEBBG
|b BV044056924
|
| 029 |
1 |
|
|a DEBSZ
|b 472814591
|
| 029 |
1 |
|
|a NZ1
|b 15499825
|
| 035 |
|
|
|a (OCoLC)874146249
|z (OCoLC)868069186
|z (OCoLC)869435448
|z (OCoLC)923424667
|z (OCoLC)961550334
|z (OCoLC)962576901
|z (OCoLC)1055319069
|z (OCoLC)1065697270
|z (OCoLC)1081260219
|z (OCoLC)1227639229
|
| 050 |
|
4 |
|a RC632.L5
|b V57 2010eb
|
| 060 |
|
4 |
|a 2010 I-616
|
| 060 |
|
4 |
|a WD 200.5.H8
|b E93 2010
|
| 060 |
|
4 |
|a WD 200.5.H8
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.399706
|2 22
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Evidence-based management of lipid disorders /
|c Maud N. Vissers, John J.P. Kastelein, Erik S. Stroes, [editors].
|
| 264 |
|
1 |
|a Harley :
|b TFM,
|c 2010.
|
| 300 |
|
|
|a 1 online resource (326 pages) :
|b illustrations (chiefly color)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a How much evidence is enough? / Daniel Steinberg -- A brief review of lipoprotein metabolism / Martin Adiels [and others] -- Epidemiological aspects of lipid and lipoprotein levels in relation to cardiovascular diseases / Jane Armitage, Louise Bowman, Sarah Lewington -- Are LDL cholesterol-lowering functional food ingredients successful in the long term? / Jogchum Plat, Ronald P. Mensink -- Evidence-based treatment of primary hypo- and hypercholesterolemic disorders / Tisha R. Joy, Robert A. Hegele -- Does raising HDL protect against atherosclerosis? / Menno Vergeer, G. Kees Hovingh -- How do we diagnose hypertriglyceridemia in clinical practice and what are the consequences for treatment? / Adie Viljoen, Anthony S. Wierzbicki -- The optimal treatment of patients with familial combined hyperlipidemia / Evertine J. Abbink, Jacqueline de Graaf, Anton F. Stalenhoef -- How to manage lipid and lipoprotein disorders in children / Serena Tonstad -- Contribution of the atherogenic dyslipidemic phenotype to the increased cardiovascular disease risk of the metabolic syndrome and diabetes mellitus / Benoit J. Arsenault, Jean-Pierre Després -- What are the consequences of renal insufficiency or the nephrotic syndrome for lipid levels? / Christiane Drechsler, Christoph Wanner, Ton Rabelink -- The link between chronic inflammatory diseases and cardiovascular risk / Michael T. Nurmohamed -- What is the evidence for a physiological and pathogenic role of lipoprotein (a)? / Sotirios Tsimikas -- Sitosterolemia; xenophobia for the body / Shailendra B. Patel, Gerald Salen -- How can we deal with inborn errors in cholesterol and bile acid biosynthesis? / Hester van Meer [and others] -- Differential diagnosis of patients with xanthomas and xanthelasmata / Peter J. Lansberg -- When should we fear statin interactions? / Rob E. Aarnoutse, David M. Burger -- What are the considerations in patients who are statin 'intolerant'? / Frans L. Opdam, Henk-Jan Guchelaar, Jouke T. Tamsma.
|
| 546 |
|
|
|a English.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Lipids
|x Metabolism
|x Disorders
|x Treatment.
|
| 650 |
|
0 |
|a Evidence-based medicine.
|
| 650 |
1 |
2 |
|a Lipid Metabolism Disorders
|x therapy
|
| 650 |
|
2 |
|a Evidence-Based Practice
|
| 650 |
2 |
2 |
|a Evidence-Based Medicine
|
| 650 |
|
6 |
|a Médecine factuelle.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Evidence-based medicine
|2 fast
|
| 700 |
1 |
|
|a Vissers, Maud N.
|
| 700 |
1 |
|
|a Kastelein, John J. P.
|
| 700 |
1 |
|
|a Stroes, Erik S.
|
| 776 |
0 |
8 |
|i Print version:
|t Evidence-based management of lipid disorders.
|d Harley : TFM, 2010
|h x, 314 pages : illustrations (chiefly color) ; 25 cm.
|z 9781903378717
|w (DLC) 2010459387
|w (OCoLC)244766419
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=685402
|z Texto completo
|
| 936 |
|
|
|a BATCHLOAD
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH26970781
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH26152004
|
| 938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL3410357
|
| 938 |
|
|
|a ebrary
|b EBRY
|n ebr10827988
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 685402
|
| 938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n cis27569286
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 11574740
|
| 994 |
|
|
|a 92
|b IZTAP
|
